Takeda Pharmaceutical (TAK) total debt

Total debt · fiscal 2026
¥4.88T

Takeda Pharmaceutical (TAK) carried total debt of ¥4.88T at the end of fiscal 2026 (March 31, 2026). That is 8.1% higher than the ¥4.52T of fiscal 2025. Figures as of 18 Nov 2026, 06:53 UTC, from Yahoo Finance.

Key facts

Total debt, fiscal 2026
¥4.88T
Change on fiscal 2025
+8.1%
Highest on record
¥4.88Tfiscal 2026
Lowest on record
¥4.38Tfiscal 2023
Fiscal years on record
42023–2026

Figures as of . Statements from Yahoo Finance. Amounts are in JPY. Figures, not advice.

Takeda Pharmaceutical total debt, in more detail

Across the 4 fiscal years on record (2023–2026), the highest was ¥4.88T in fiscal 2026 and the lowest ¥4.38T in fiscal 2023.

Total debt was 0.7× shareholders' equity at the end of fiscal 2026.

History · 4 fiscal years

Total debt by fiscal year

Takeda Pharmaceutical total debt, year by year

Takeda Pharmaceutical (TAK) total debt by fiscal year
Fiscal yearTotal debtChangeYear endedDebt ÷ equity
2026¥4.88T 8.1% up0.7×
2025¥4.52T 6.8% down0.7×
2024¥4.84T 10.5% up0.7×
2023¥4.38T—0.7×

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

How to read it

Debt magnifies results in both directions — set it against cash, equity and the profit available to pay the interest rather than reading it alone.

Total debt at health care companies of similar size

Total debt of Takeda Pharmaceutical and comparable companies
CompanyTotal debtFiscal year
Takeda Pharmaceutical TAK¥4.88T2026
Cencora COR$7.66B2025
Boston Scientific BSX$11.44B2025
Cardinal Health CAH$8.89B2026
argenx ARGX$47.16M2025
Edwards Lifesciences EW$705.40M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on TAK

Takeda Pharmaceutical, figure by figure

Takeda Pharmaceutical (TAK) overview: price, valuation and scorecardAll health care companies by market value

Takeda Pharmaceutical total debt: questions and answers

How much debt does Takeda Pharmaceutical have?

Takeda Pharmaceutical (TAK) carried total debt of ¥4.88T at the end of fiscal 2026 (March 31, 2026). That is 8.1% higher than the ¥4.52T of fiscal 2025.

What are the highest and lowest total debt figures on record for Takeda Pharmaceutical?

Across the 4 fiscal years on record (2023–2026), the highest was ¥4.88T in fiscal 2026 and the lowest ¥4.38T in fiscal 2023.

How does Takeda Pharmaceutical's debt compare with its equity?

Total debt was 0.7× shareholders' equity at the end of fiscal 2026.

How is Takeda Pharmaceutical's total debt calculated?

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Takeda Pharmaceutical (TAK) total debt”, data as of 18 November 2026. https://funkfolio.com/stock/TAK/total-debt

Underlying data: Yahoo Finance.